Welcome to HitGen

Capabilities

One-stop Technology Platform to Accelerate Drug Discovery and Development

  1. Capabilities
  2. Target Nomination and Analysis

Target Nomination and Analysis

Target feasibility analysis are applied throughout the target nomination and hit identification step. A feasible therapeutic target is evaluated in multiple aspects as listed below.


  • Literature review of the target to gain enough understanding of the target. The biological evidence as a therapeutic target, the mechanism of action, and the biological assays are all assessed in this stage. 


  • A comprehensive review of the market and the competitive products. Differentiation is emphasized when determine the target product profile. 


  • HitGen is equipped with multiple drug discovery platforms including but not limited to DEL, FBDD/SBDD, CADD, and siRNA platform. Our analysts will determine the most optimal method (or methods) to use based on the characteristics of the target. 

Questions?

For more details on how we can advance your innovative drug discovery projects
By submitting your information, you acknowledge having received, read and understood our Privacy Notice as made available above.

We use cookies to provide a better web experience.
By using our site, you acknowledge our use of cookies and please read our Cookie Notice for More information